174 related articles for article (PubMed ID: 37444140)
1. Patient-Reported Outcome Measures in Liver and Gastrointestinal Cancer Randomized Controlled Trials.
Winkelmann C; Mezentseva A; Vogt B; Neumann T
Int J Environ Res Public Health; 2023 Jul; 20(13):. PubMed ID: 37444140
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of patient-reported outcome measures for advanced skin cancer patients.
Reinhardt ME; Sun T; Pan CX; Schmults CD; Lee EH; Waldman AB
Arch Dermatol Res; 2023 Aug; 315(6):1473-1480. PubMed ID: 36469125
[TBL] [Abstract][Full Text] [Related]
3. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.
Ratti MM; Gandaglia G; Alleva E; Leardini L; Sisca ES; Derevianko A; Furnari F; Mazzoleni Ferracini S; Beyer K; Moss C; Pellegrino F; Sorce G; Barletta F; Scuderi S; Omar MI; MacLennan S; Williamson PR; Zong J; MacLennan SJ; Mottet N; Cornford P; Aiyegbusi OL; Van Hemelrijck M; N'Dow J; Briganti A;
Eur Urol Oncol; 2022 Apr; 5(2):153-163. PubMed ID: 34785188
[TBL] [Abstract][Full Text] [Related]
4. The association of liver function and quality of life of patients with liver cancer.
Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W
BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687
[TBL] [Abstract][Full Text] [Related]
5. Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7).
King MT; Agar M; Currow DC; Hardy J; Fazekas B; McCaffrey N
Support Care Cancer; 2020 Jan; 28(1):141-153. PubMed ID: 30993452
[TBL] [Abstract][Full Text] [Related]
6. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
[TBL] [Abstract][Full Text] [Related]
8. International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18.
Chie WC; Blazeby JM; Hsiao CF; Chiu HC; Poon RT; Mikoshiba N; Al-Kadhimi G; Heaton N; Calara J; Collins P; Caddick K; Costantini A; Vilgrain V; Trinquart L; Chiang C;
Hepatology; 2012 Apr; 55(4):1122-9. PubMed ID: 22105642
[TBL] [Abstract][Full Text] [Related]
9. The current practice of handling and reporting missing outcome data in eight widely used PROMs in RCT publications: a review of the current literature.
Rombach I; Rivero-Arias O; Gray AM; Jenkinson C; Burke Ó
Qual Life Res; 2016 Jul; 25(7):1613-23. PubMed ID: 26821918
[TBL] [Abstract][Full Text] [Related]
10. Quality-of-life methodology in hormone receptor-positive advanced breast cancer: Current tools and perspectives for the future.
Cardoso F; Cella D; Velikova G; Harmer V; Schumacher-Wulf E; Rihani J; Casas A; Harbeck N
Cancer Treat Rev; 2022 Jan; 102():102321. PubMed ID: 34852292
[TBL] [Abstract][Full Text] [Related]
11. Systematic review of patient-reported outcome measures in the surgical treatment of patients with esophageal cancer.
Straatman J; Joosten PJ; Terwee CB; Cuesta MA; Jansma EP; van der Peet DL
Dis Esophagus; 2016 Oct; 29(7):760-772. PubMed ID: 26471471
[TBL] [Abstract][Full Text] [Related]
12. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry.
Husson O; de Rooij BH; Kieffer J; Oerlemans S; Mols F; Aaronson NK; van der Graaf WTA; van de Poll-Franse LV
Oncologist; 2020 Apr; 25(4):e722-e732. PubMed ID: 32297435
[TBL] [Abstract][Full Text] [Related]
13. Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series.
Hjermstad MJ; Jakobsen G; Arends J; Balstad TR; Brown LR; Bye A; Coats AJS; Dajani OF; Dolan RD; Fallon MT; Greil C; Grzyb A; Kaasa S; Koteng LH; May AM; McDonald J; Ottestad I; Philips I; Roeland EJ; Sayers J; Simpson MR; Skipworth RJE; Solheim TS; Sousa MS; Vagnildhaug OM; Laird BJA;
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):794-815. PubMed ID: 38553255
[TBL] [Abstract][Full Text] [Related]
14. Health related quality of life following open versus minimally invasive total gastrectomy for cancer: Results from a randomized clinical trial.
van der Wielen N; Daams F; Rosati R; Parise P; Weitz J; Reissfelder C; Diez Del Val I; Loureiro C; Parada-González P; Pintos-Martínez E; Vallejo FM; Achirica CM; Sánchez-Pernaute A; Campos AR; Bonavina L; Asti ELG; Poza AA; Gilsanz C; Nilsson M; Lindblad M; Gisbertz SS; van Berge Henegouwen MI; Romario UF; De Pascale S; Akhtar K; Bonjer HJ; Cuesta MA; van der Peet DL; Straatman J
Eur J Surg Oncol; 2022 Mar; 48(3):553-560. PubMed ID: 34503850
[TBL] [Abstract][Full Text] [Related]
15. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
[TBL] [Abstract][Full Text] [Related]
16. Differences in Patient-Reported Outcomes That Are Most Frequently Detected in Randomized Controlled Trials in Patients With Solid Tumors: A Pooled Analysis of 229 Trials.
Giesinger JM; Blazeby J; Aaronson NK; Sprangers M; Fayers P; Sparano F; Rees J; Anota A; Wan C; Pezold M; Isharwal S; Cottone F; Efficace F;
Value Health; 2020 May; 23(5):666-673. PubMed ID: 32389233
[TBL] [Abstract][Full Text] [Related]
17. Assessing the quality of patient-reported outcome measurements for gynecological cancers: a systematic review.
Moss CL; Guerrero-Urbano T; White I; Taylor B; Kristeleit R; Montes A; Fox L; Beyer K; Sztankay M; Ratti MM; Sisca ES; Derevianko A; MacLennan S; Wood N; Wintner LM; Van Hemelrijck M
Future Oncol; 2023 Mar; 19(9):663-678. PubMed ID: 37128990
[TBL] [Abstract][Full Text] [Related]
18. Quality of life assessments in clinical practice using either the EORTC-QLQ-C30 or the SEIOQL-DW: a randomized study.
Kettis Å; Fagerlind H; Frödin JE; Glimelius B; Ring L
J Patient Rep Outcomes; 2021 Jul; 5(1):58. PubMed ID: 34259966
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Reporting of health-related quality of life (HRQOL) data in oncology trials: a comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT-G).
Smith AB; Cocks K; Parry D; Taylor M
Qual Life Res; 2014 Apr; 23(3):971-6. PubMed ID: 24097080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
